Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Alzheimer's Disease Health Center

Font Size

New Recommendations for Alzheimer's Diagnosis

Experts Propose 3 Stages Aimed at Earlier Detection

New Criteria for Diagnosis of Alzheimer's: A Closer Look continued...

Experts in Alzheimer's disease were tapped to work on the updated criteria.

Among the advances important to consider in setting up the proposed diagnostic criteria, according to the Alzheimer's Association, is:

  • Changes in the brain triggered by Alzheimer's develop slowly over many years, reflecting the importance of catching the disease earlier.
  • Genes can help predict a form of the disease known as early-onset Alzheimer's; these genetic observations indicate that the initial brain event that leads to symptoms and the brain changes begin with disordered beta-amyloid metabolism.
  • An alternative form of the ApoE gene is now known as a major genetic risk factor for the more common late-onset disease.
  • Much is known about biomarkers and ongoing research is validating these biomarkers.

For each of the stages, the workgroups have suggestions, Morris says.

  • The first workgroup, on pre-clinical disease , suggests thinking about Alzheimer's disease not just as dementia, but a brain disorder that begins years before symptoms occur. "This pre-clinical stage may be important for future research," Morris says, hopefully leading to intervention strategies and eventually prevention.
  • The second, on mild cognitive impairment, also suggests incorporating biomarkers to better differentiate the stages of the disease.
  • The third, on Alzheimer’s dementia, suggests that the inclusion of biomarkers will increase the confidence of the diagnosis.

What's Next?

The Alzheimer's Association and the National Institute on Aging are launching a web site at criteria to solicit input from additional experts.

"The criteria are open for comment until September 2010," Thies says. Then the criteria will be published in a peer-reviewed medical journal.

As to the effect on patients, Thies expects very little effect short term. "Long term, people will be layered into three groups," he says, depending on their symptoms and diagnosis. Those with mild cognitive impairment, now underrepresented in research studies, will be included in larger numbers, he says.

1 | 2

Today on WebMD

Remember your finger
When it’s more than just forgetfulness.
senior man with serious expression
Which kinds are treatable?
senior man
Common symptoms to look for.
mri scan of human brain
Can drinking red wine reverse the disease?
eating blueberries
Colored mri of brain
Close up of elderly couple holding hands
mature woman
Woman comforting ailing mother
Senior woman with serious expression